Unit
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
BRCA2 germline mutation carrier with five malignancies: a case report.
Su E, Christinat Y, McKee T, Azzarello-Burri S, Jochum W, Fischer S, Rothermundt C. BRCA2 germline mutation carrier with five malignancies: a case report. Hered Cancer Clin Pract 2024; 22:27.
Dec 19, 2024BRCA2 germline mutation carrier with five malignancies: a case report.
Dec 19, 2024Hered Cancer Clin Pract 2024; 22:27
Su Elena, Christinat Yann, McKee Thomas, Azzarello-Burri Silvia, Jochum Wolfram, Fischer Stefanie, Rothermundt Christian
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial.
Reimer T, Stachs A, Veselinovic K, Kühn T, Heil J, Polata S, Marme F, Müller T, Hildebrandt G, Krug D, Ataseven B, Reitsamer R, Ruth S, Denkert C, Bekes I, Zahm D, Thill M, Golatta M, Holtschmidt J, Knauer M, Nekljudova V, Loibl S, Gerber B. Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial. N Engl J Med 2024
Dec 12, 2024Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial.
Dec 12, 2024N Engl J Med 2024
Reimer Toralf, Stachs Angrit, Veselinovic Kristina, Kühn Thorsten, Heil Jörg, Polata Silke, Marme Frederik, Müller Thomas F, Hildebrandt Guido, Krug David, Ataseven Beyhan, Reitsamer Roland, Ruth Sylvia, Denkert Carsten, Bekes Inga, Zahm Dirk-Michael, Thill Marc, Golatta Michael, Holtschmidt Johannes, Knauer Michael, Nekljudova Valentina, Loibl Sibylle, Gerber Bernd
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.
Melero I, de Miguel Luken M, de Velasco G, Garralda E, Martin-Liberal J, Jörger M, Alonso G, Goebeler M, Schuler M, König D, Dummer R, Reig M, Rodriguez Ruiz M, Calvo E, Esteban-Villarrubia J, Oberoi A, Sabat P, Soto-Castillo J, Koster K, Saavedra O, Sayehli C, Gromke T, Läubli H, Ramelyte E, Fortuny M, Landa-Magdalena A, Moreno I, Torres-Jiménez J, Hernando-Calvo A, Hess D, Racca F, Richly H, Schmitt A, Eggenschwiler C, Sanduzzi-Zamparelli M, Vilalta-Lacarra A, Trojan J, Koch C, Galle P, Foerster F, Trajanoski Z, Hackl H, Gogolla F, Koll F, Wild P, Chun F, Reis H, Lloyd P, Machacek M, Gajewski T, Fridman W, Eggermont A, Bargou R, Schöniger S, Rüschoff J, Tereshchenko A, Zink C, Dantas-Silva A, Lichtenegger F, Akdemir J, Rüdiger M, L'Huillier P, Dutta A, Haake M, Auckenthaler A, Gjorgjioska A, Rössler B, Hermann F, Liebig M, Reichhardt D, Schuberth-Wagner C, Wischhusen J, Fettes P, Auer M, Klar K, Leo E. Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours. Nature 2024
Dec 11, 2024Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours.
Dec 11, 2024Nature 2024
Melero Ignacio, de Miguel Luken Maria, de Velasco Guillermo, Garralda Elena, Martin-Liberal Juan, Jörger Markus, Alonso Guzman, Goebeler Maria-Elisabeth, Schuler Martin, König David, Dummer Reinhard, Reig Maria, Rodriguez Ruiz Maria-Esperanza, Calvo Emiliano, Esteban-Villarrubia Jorge, Oberoi Arjun, Sabat Paula, Soto-Castillo Juan José, Koster Kira-Lee, Saavedra Omar, Sayehli Cyrus Michael, Gromke Tanja, Läubli Heinz, Ramelyte Egle, Fortuny Marta, Landa-Magdalena Ana, Moreno Irene, Torres-Jiménez Javier, Hernando-Calvo Alberto, Hess Dagmar, Racca Fabricio, Richly Heike, Schmitt Andreas Michael, Eggenschwiler Corinne, Sanduzzi-Zamparelli Marco, Vilalta-Lacarra Anna, Trojan Jörg, Koch Christine, Galle Peter R, Foerster Friedrich, Trajanoski Zlatko, Hackl Hubert, Gogolla Falk, Koll Florestan J, Wild Peter J, Chun Felix Kyoung Hwan, Reis Henning, Lloyd Peter, Machacek Matthias, Gajewski Thomas F, Fridman Wolf H, Eggermont Alexander M M, Bargou Ralf C, Schöniger Sandra, Rüschoff Josef, Tereshchenko Anastasiia, Zink Carina, Dantas-Silva Amanda, Lichtenegger Felix S, Akdemir Julia, Rüdiger Manfred, L'Huillier Phil, Dutta Aradhana, Haake Markus, Auckenthaler Alexandra, Gjorgjioska Ana, Rössler Bernhard, Hermann Frank, Liebig Mara, Reichhardt Daniela, Schuberth-Wagner Christine, Wischhusen Jörg, Fettes Petra, Auer Marlene, Klar Kathrin, Leo Eugen
High iASPP (PPP1R13L) expression is an independent predictor of adverse clinical outcome in acute myeloid leukemia (AML).
Bajrami Saipi M, Ruiba A, Schittenhelm M, Blumenstock G, Győrffy B, Fazio S, Hafner M, Ahrens A, Aldinger L, Aellig V, Kavelaars F, Nombela-Arrieta C, Fend F, Valk P, Driessen C, Kampa-Schittenhelm K. High iASPP (PPP1R13L) expression is an independent predictor of adverse clinical outcome in acute myeloid leukemia (AML). Cell Death Dis 2024; 15:869.
Nov 30, 2024High iASPP (PPP1R13L) expression is an independent predictor of adverse clinical outcome in acute myeloid leukemia (AML).
Nov 30, 2024Cell Death Dis 2024; 15:869
Bajrami Saipi Mihada, Ruiba Alessia, Schittenhelm Marcus, Blumenstock Gunnar, Győrffy Balázs, Fazio Serena, Hafner Marlon, Ahrens Anna-Lena, Aldinger Lara, Aellig Vanessa, Kavelaars François G, Nombela-Arrieta César, Fend Falko, Valk Peter J M, Driessen Christoph, Kampa-Schittenhelm Kerstin
Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer.
Denkert C, Schneeweiss A, Rey J, Karn T, Hattesohl A, Weber K, Rachakonda S, Braun M, Huober J, Jank P, Sinn H, Zahm D, Felder B, Hanusch C, Teply-Szymanski J, Marme F, Fehm T, Thomalla J, Sinn B, Stiewe T, Marczyk M, Blohmer J, van Mackelenbergh M, Schem C, Staib P, Link T, Müller V, Stickeler E, Stover D, Solbach C, Metzger-Filho O, Jackisch C, Geyer C, Fasching P, Pusztai L, Nekljudova V, Untch M, Loibl S. Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer. Cell Rep Med 2024; 5:101825.
Nov 19, 2024Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer.
Nov 19, 2024Cell Rep Med 2024; 5:101825
Denkert Carsten, Schneeweiss Andreas, Rey Julia, Karn Thomas, Hattesohl Akira, Weber Karsten E, Rachakonda Sivaramakrishna, Braun Michael, Huober Jens, Jank Paul, Sinn Hans-Peter, Zahm Dirk-Michael, Felder Bärbel, Hanusch Claus, Teply-Szymanski Julia, Marme Frederik, Fehm Tanja N, Thomalla Jörg, Sinn Bruno Valentin, Stiewe Thorsten, Marczyk Michal, Blohmer Jens-Uwe, van Mackelenbergh Marion T, Schem Christian, Staib Peter, Link Theresa, Müller Volkmar, Stickeler Elmar, Stover Daniel G, Solbach Christine, Metzger-Filho Otto, Jackisch Christian, Geyer Charles E, Fasching Peter Andreas, Pusztai Lajos, Nekljudova Valentina, Untch Michael, Loibl Sibylle
Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights.
Singh N, Früh M, Gubens M, Ismaila N, Daly M. Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights. JCO Oncol Pract 2024:OP2400784.
Nov 18, 2024Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights.
Nov 18, 2024JCO Oncol Pract 2024:OP2400784
Singh Navneet, Früh Martin, Gubens Matthew A, Ismaila Nofisat, Daly Megan E
Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment.
Schmid S, Holer L, Gysel K, Koster K, Rothschild S, Boos L, Frehner L, Cardoso Almeida S, Britschgi C, Metaxas Y, Mark M, Froesch P, Janthur W, Allemann A, Waibel C, Von der Mühll-Schill C, Früh M, Mauti L. Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment. JTO Clin Res Rep 2024; 5:100735.
Oct 15, 2024Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment.
Oct 15, 2024JTO Clin Res Rep 2024; 5:100735
Schmid Sabine, Holer Lisa, Gysel Katrin, Koster Kira-Lee, Rothschild Sacha I, Boos Laura A, Frehner Lorenz, Cardoso Almeida Sabine, Britschgi Christian, Metaxas Yannis, Mark Michael, Froesch Patrizia, Janthur Wolf-Dieter, Allemann Anna, Waibel Christine, Von der Mühll-Schill Catherine, Früh Martin, Mauti Laetitia A
Immune triggers preceding neuralgic amyotrophy.
Sparasci D, Schilg-Hafer L, Schreiner B, Scheidegger O, Peyer A, Lascano A, Vicino A, Décard B, Tsouni P, Humm A, Pianezzi E, Zezza G, Hundsberger T, Dietmann A, Jung H, Kuntzer T, Wilder-Smith E, Martinetti-Lucchini G, Petrini O, Fontana S, Gowland P, Niederhauser C, Gobbi C, Ripellino P. Immune triggers preceding neuralgic amyotrophy. Eur J Neurol 2024; 31:e16462.
Oct 4, 2024Immune triggers preceding neuralgic amyotrophy.
Oct 4, 2024Eur J Neurol 2024; 31:e16462
Sparasci Davide, Schilg-Hafer Lenka, Schreiner Bettina, Scheidegger Olivier, Peyer Anne-Kathrin, Lascano Agustina Maria, Vicino Alex, Décard Bernhard Friedrich, Tsouni Pinelopi, Humm Andrea Monika, Pianezzi Enea, Zezza Giulia, Hundsberger Thomas, Dietmann Anelia, Jung Hans H, Kuntzer Thierry, Wilder-Smith Einar, Martinetti-Lucchini Gladys, Petrini Orlando, Fontana Stefano, Gowland Peter, Niederhauser Christoph, Gobbi Claudio, Ripellino Paolo
Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate.
Schaefer T, Mittal N, Wang H, Ataman M, Candido S, Lötscher J, Velychko S, Tintignac L, Bock T, Börsch A, Baßler J, Rao T, Zmajkovic J, Roffeis S, Loeliger J, Jacob F, Dumlin A, Schürch C, Schmidt A, Skoda R, Wymann M, Hess C, Schöler H, Zaehres H, Hurt E, Zavolan M, Lengerke C. Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate. Cell Rep 2024; 43:114807.
Oct 3, 2024Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate.
Oct 3, 2024Cell Rep 2024; 43:114807
Schaefer Thorsten, Mittal Nitish, Wang Hui, Ataman Meric, Candido Silvia, Lötscher Jonas, Velychko Sergiy, Tintignac Lionel, Bock Thomas, Börsch Anastasiya, Baßler Jochen, Rao Tata Nageswara, Zmajkovic Jakub, Roffeis Sarah, Loeliger Jordan, Jacob Francis, Dumlin Alain, Schürch Christoph, Schmidt Alexander, Skoda Radek C, Wymann Matthias P, Hess Christoph, Schöler Hans R, Zaehres Holm, Hurt Ed, Zavolan Mihaela, Lengerke Claudia
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
Wyss N, Berner F, Walter V, Jochum A, Purde M, Abdou M, Sinnberg T, Hofmeister K, Pop O, Hasan A, Bauer J, Cheng H, Lütge M, Klümper N, Diem S, Kosaloglu-Yalcin Z, Zhang Y, Sellmer L, Macek B, Karbach J, König D, Läubli H, Zender L, Meyer B, Driessen C, Schürch C, Jochum W, Amaral T, Heinzerling L, Cozzio A, Hegazy A, Schneider T, Brutsche M, Sette A, Lenz T, Walz J, Rammensee H, Früh M, Jäger E, Becher B, Tufman A, Núñez N, Jörger M, Flatz L. Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade. Am J Respir Crit Care Med 2024; 210:919-930.
Oct 1, 2024Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
Oct 1, 2024Am J Respir Crit Care Med 2024; 210:919-930
Wyss Nina, Berner Fiamma, Walter Vincent, Jochum Ann-Kristin, Purde Mette T, Abdou Marie-Therese, Sinnberg Tobias, Hofmeister Kathrin, Pop Oltin, Hasan Ali, Bauer Jens, Cheng Hung-Wei, Lütge Mechthild, Klümper Niklas, Diem Stefan, Kosaloglu-Yalcin Zeynep, Zhang Yizheng, Sellmer Laura, Macek Boris, Karbach Julia, König David, Läubli Heinz, Zender Lars, Meyer Britta S, Driessen Christoph, Schürch Christian M, Jochum Wolfram, Amaral Teresa, Heinzerling Lucie M, Cozzio Antonio, Hegazy AhN, Schneider Tino, Brutsche Martin, Sette Alessandro, Lenz Tobias L, Walz Juliane Sarah, Rammensee Hans-Georg, Früh Martin, Jäger Elke, Becher Burkhard, Tufman Amanda, Núñez Nicolás Gonzalo, Jörger Markus, Flatz Lukas
Factors Guiding Clinical Decision-Making in Genitourinary Oncology.
Wosny M, Aeppli S, Fischer S, Peres T, Rothermundt C, Hastings J. Factors Guiding Clinical Decision-Making in Genitourinary Oncology. Cancer Med 2024; 13:e70304.
Oct 1, 2024Factors Guiding Clinical Decision-Making in Genitourinary Oncology.
Oct 1, 2024Cancer Med 2024; 13:e70304
Wosny Marie, Aeppli Stefanie, Fischer Stefanie, Peres Tobias, Rothermundt Christian, Hastings Janna
Validation of a Textile-Based Wearable Measuring Electrocardiogram and Breathing Frequency for Sleep Apnea Monitoring.
Baty F, Cvetković D, Bösch M, Bauer F, Martins N, Rossi R, Schoch O, Annaheim S, Brutsche M. Validation of a Textile-Based Wearable Measuring Electrocardiogram and Breathing Frequency for Sleep Apnea Monitoring. Sensors (Basel) 2024; 24
Sep 26, 2024Validation of a Textile-Based Wearable Measuring Electrocardiogram and Breathing Frequency for Sleep Apnea Monitoring.
Sep 26, 2024Sensors (Basel) 2024; 24
Baty Florent, Cvetković Dragan, Bösch Maximilian, Bauer Frederik, Martins Neusa R Adão, Rossi René Michel, Schoch Otto, Annaheim Simon, Brutsche Martin
Is personal physiology-based rapid prediction digital twin for minimal effective fentanyl dose better than standard practice: a pilot study protocol.
Cukic M, Annaheim S, Bahrami F, Defraeye T, De Nys K, Jörger M. Is personal physiology-based rapid prediction digital twin for minimal effective fentanyl dose better than standard practice: a pilot study protocol. BMJ Open 2024; 14:e085296.
Sep 24, 2024Is personal physiology-based rapid prediction digital twin for minimal effective fentanyl dose better than standard practice: a pilot study protocol.
Sep 24, 2024BMJ Open 2024; 14:e085296
Cukic Milena, Annaheim Simon, Bahrami Flora, Defraeye Thijs, De Nys Katelijne, Jörger Markus
On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer.
Sinn B, Sychra K, Untch M, Karn T, van Mackelenbergh M, Huober J, Schmitt W, Marme F, Schem C, Solbach C, Stickeler E, Tesch H, Fasching P, Schneeweiss A, Müller V, Holtschmidt J, Nekljudova V, Loibl S, Denkert C. On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer. Breast Cancer Res 2024; 26:138.
Sep 24, 2024On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer.
Sep 24, 2024Breast Cancer Res 2024; 26:138
Sinn Bruno Valentin, Sychra Katharina, Untch Michael, Karn Thomas, van Mackelenbergh Marion T, Huober Jens, Schmitt Wolfgang Daniel, Marme Frederik, Schem Christian, Solbach Christine, Stickeler Elmar, Tesch Hans, Fasching Peter Andreas, Schneeweiss Andreas, Müller Volkmar, Holtschmidt Johannes, Nekljudova Valentina, Loibl Sibylle, Denkert Carsten
First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Fischer S, Gillessen S, Stalder O, Terbuch A, Cathomas R, Schmid F, Zihler D, Müller-Stich B, Fankhauser C, Hirschi-Blickenstorfer A, Alex Kluth L, Seifert B, Templeton A, Mingrone W, Ufe M, Fischer N, Beyer J, Woelky R, Omlin A, Vogl U, Hoppe K, Kamradt J, Rothschild S, Rothermundt C. First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS). Eur Urol Open Sci 2024; 68:68-74.
Sep 11, 2024First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
Sep 11, 2024Eur Urol Open Sci 2024; 68:68-74
Fischer Stefanie, Gillessen Silke, Stalder Odile, Terbuch Angelika, Cathomas Richard, Schmid Florian, Zihler Deborah, Müller-Stich Beat P, Fankhauser Christian Daniel, Hirschi-Blickenstorfer Anita, Alex Kluth Luis, Seifert Bettina, Templeton Arnoud J, Mingrone Walter, Ufe Mark-Peter, Fischer Natalie Fischer, Beyer Jörg, Woelky Regina, Omlin Aurelius, Vogl Ursula M, Hoppe Katharina, Kamradt Jörn, Rothschild Sacha I, Rothermundt Christian
Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies.
Goede J, Baumann C, Cathomas R, Khanna N, Lambert J, Lehmann T, Mey U, Seebach J, Steiner U, Tschan-Plessl A, Stenner-Liewen F. Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies. Swiss Med Wkly 2024; 154:3559.
Sep 9, 2024Rational use of immunoglobulins (IVIgs and SCIgs) in secondary antibody deficiencies.
Sep 9, 2024Swiss Med Wkly 2024; 154:3559
Goede Jeroen, Baumann Christa K, Cathomas Richard, Khanna Nina, Lambert Jean-Francois, Lehmann Thomas, Mey Ulrich J M, Seebach Jörg, Steiner U C, Tschan-Plessl Astrid, Stenner-Liewen Frank
JAK2 impairs lymphoid differentiation in myeloproliferative neoplasms.
Choi D, Messali N, Uda N, Abu-Zeinah G, Kermani P, Yabut M, Lischer H, Castillo Tokumori F, Erdos K, Lehmann T, Sobas M, Rao T, Scandura J. JAK2 impairs lymphoid differentiation in myeloproliferative neoplasms. Leukemia 2024; 38:2487-2491.
Sep 7, 2024JAK2 impairs lymphoid differentiation in myeloproliferative neoplasms.
Sep 7, 2024Leukemia 2024; 38:2487-2491
Choi Daniel C, Messali Nassima, Uda Narasimha Rao, Abu-Zeinah Ghaith, Kermani Pouneh, Yabut Maria Mia, Lischer Heidi E L, Castillo Tokumori Franco, Erdos Katie, Lehmann Thomas, Sobas Marta, Rao Tata Nageswara, Scandura Joseph M
Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale.
van Kooten H, Horton M, Wenninger S, Babačić H, Schoser B, Lefeuvre C, Taouagh N, Laforet P, Segovia S, Diaz-Manera J, Claeys K, Mongini T, Musumeci O, Toscano A, Hundsberger T, Brusse E, van Doorn P, van der Ploeg A, van der Beek N, European Pompe Consortium study group on outcome measures. Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale. Eur J Neurol 2024; 31:e16397.
Aug 28, 2024Improving outcome measures in late onset Pompe disease: Modified Rasch-Built Pompe-Specific Activity scale.
Aug 28, 2024Eur J Neurol 2024; 31:e16397
van Kooten Harmke A, Horton Mike C, Wenninger Stephan, Babačić Haris, Schoser Benedikt, Lefeuvre Claire, Taouagh Najib, Laforet Pascal, Segovia Sonia, Diaz-Manera Jordi, Claeys Kristl G, Mongini Tiziana, Musumeci Olimpia, Toscano Antonio, Hundsberger Thomas, Brusse Esther, van Doorn Pieter A, van der Ploeg Ans T, van der Beek Nadine A M E, European Pompe Consortium study group on outcome measures
Tracking Real-World Physical Activity in Chronic Obstructive Pulmonary Disease Over One Year: Results from a Monocentric, Prospective, Observational Cohort Study.
Bösch M, Baty F, Bilz S, Brutsche M, Rassouli F. Tracking Real-World Physical Activity in Chronic Obstructive Pulmonary Disease Over One Year: Results from a Monocentric, Prospective, Observational Cohort Study. Int J Chron Obstruct Pulmon Dis 2024; 19:1921-1929.
Aug 27, 2024Tracking Real-World Physical Activity in Chronic Obstructive Pulmonary Disease Over One Year: Results from a Monocentric, Prospective, Observational Cohort Study.
Aug 27, 2024Int J Chron Obstruct Pulmon Dis 2024; 19:1921-1929
Bösch Maximilian, Baty Florent, Bilz Stefan, Brutsche Martin, Rassouli Frank
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer.
Möbus V, Lück H, Ladda E, Klare P, Engels K, Schmidt M, Schneeweiss A, Grischke E, Wachsmann G, Forstbauer H, Untch M, Marme F, Blohmer J, Jackisch C, Huober J, Stickeler E, Reinisch M, Link T, Sinn B, Janni W, Denkert C, Seiler S, Solbach C, Schmatloch S, Rey J, Loibl S. GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer. NPJ Breast Cancer 2024; 10:66.
Jul 30, 2024GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer.
Jul 30, 2024NPJ Breast Cancer 2024; 10:66
Möbus Volker, Lück Hans-Joachim, Ladda Ekkehart, Klare Peter, Engels Knut, Schmidt Marcus, Schneeweiss Andreas, Grischke Eva-Maria, Wachsmann Grischa, Forstbauer Helmut, Untch Michael, Marme Frederik, Blohmer Jens-Uwe, Jackisch Christian, Huober Jens, Stickeler Elmar, Reinisch Mattea, Link Theresa, Sinn Bruno Valentin, Janni Wolfgang, Denkert Carsten, Seiler Sabine, Solbach Christine, Schmatloch Sabine, Rey Julia, Loibl Sibylle